Sabadell - Bayer AG (BAYN) BAYER: DIVISIÓN EN EL TRIBUNAL SUPREMO (ANÁLISIS BANCO SABADELL)

Report

Sabadell

Rafael Bonardell

EUR 50.00 For Business Accounts Only

BAYER: DIVISIÓN EN EL TRIBUNAL SUPREMO (ANÁLISIS BANCO SABADELL)

Ayer, durante la vista de la revisión del caso glifosato en el Tribunal Supremo de EE.UU., los diferentes jueces se mostraron divididos sobre si la ley federal bloquea/evita reclamaciones estatales por falta de advertencia de cáncer en el etiquetado de Roundup (herbicida de BAYN a base de glifosato), siendo este el punto clave a resolver.

28/04/2026 1 ES

Underlying

Bayer AG

Bayer is a life sciences group based in Germany. Co.'s operations are organized along three divisions: Pharmaceuticals (engaged in prescription pharmaceuticals for cardiology and women's healthcare); Consumer Health (engaged in non-prescription products in dermatology, dietary supplement, analgesic, gastrointestinal, allergy, cold and flu, foot care, sun protection and cardiovascular risk prevention categories); and CropScience (engaged in the development of seeds and plant traits; crop protection; and for gardens, the green industry and non-agricultural pest control). Co. also maintains an Animal Health business unit engaged in the development of products for farm and companion animals.

See profile

DE000BAY0017 Germany

Provider

Sabadell

See profile

Analysts

Rafael Bonardell

Other Reports on these Companies

Moody's Investors Service

Bayer AG - December 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

April 9, 2026 April 9, 2026 1 EN

SmartInsider

Bayer AG: 1 director

A director at Bayer AG sold 8,319,898 shares at 37.250EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

Free Trial

March 26, 2026 March 26, 2026 1 EN

AIR LIQUIDE: MENSAJES DE LA CONFERENCE CALL VENTAS 1T’26 (ANÁLISIS BANCO SABADELL)

De la conference call de Ventas 1T’26 destacamos:

EUR 50.00

2h / 33m 2h / 33m 1 ES

Teresa Ortiz

Teresa Ortiz

AIR LIQUIDE: VENTAS 1T’26 (ANÁLISIS BANCO SABADELL)

Rdos. 1T'26 vs 1T'25: Ventas: 6.786 M euros (-3,6% vs -2,9% consenso).

EUR 100.00

6h / 47m 6h / 47m 1 ES

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

BAYER: DIVISIÓN EN EL TRIBUNAL SUPREMO (ANÁLISIS BANCO SABADELL)

Bayer AG - December 2025 (LTM): Peer Snapshot

Bayer AG: 1 director

AIR LIQUIDE: MENSAJES DE LA CONFERENCE CALL VENTAS 1T’26 (ANÁLISIS BANCO SABADELL)

AIR LIQUIDE: VENTAS 1T’26 (ANÁLISIS BANCO SABADELL)

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe